| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.09B | $ 1.14B | $ 1.13B | $ 1.13B | $ 1.09B |
| Gross Profit | $ 574.64M | $ 634.46M | $ 624.45M | $ 625.29M | $ 620.65M |
| Operating Income | $ 309.41M | $ 336.77M | $ 342.43M | $ -22.41M | $ 329.92M |
| EBITDA | $ 331.11M | $ 361.99M | $ 373.86M | $ 7.87M | $ 358.84M |
| Net Income | $ 190.30M | $ 214.60M | $ 209.34M | $ -82.31M | $ 205.38M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 63.87M | $ 97.88M | $ 46.47M | $ 58.49M | $ 27.18M |
| Total Assets | $ 3.55B | $ 3.40B | $ 3.32B | $ 3.35B | $ 3.67B |
| Total Debt | $ 1.05B | $ 1.04B | $ 1.14B | $ 1.37B | $ 1.51B |
| Net Debt | $ 981.56M | $ 946.37M | $ 1.09B | $ 1.31B | $ 1.48B |
| Total Liabilities | $ 1.66B | $ 1.57B | $ 1.66B | $ 1.91B | $ 2.09B |
| Stockholders' Equity | $ 1.89B | $ 1.83B | $ 1.66B | $ 1.45B | $ 1.58B |
| Cash Flow | |||||
| Free Cash Flow | $ 254.23M | $ 243.29M | $ 239.38M | $ 221.93M | $ 250.28M |
| Operating Cash Flow | $ 265.41M | $ 251.51M | $ 248.93M | $ 229.72M | $ 259.92M |
| Investing Cash Flow | $ -136.84M | $ -17.45M | $ -20.11M | $ -11.58M | $ -256.51M |
| Financing Cash Flow | $ -163.84M | $ -182.07M | $ -241.01M | $ -185.85M | $ -7.57M |
Prestige Consumer Healthcare (DE:PBV)
NYSE:PBV
